Lukatch Heath 4
4 · Vaxcyte, Inc. · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Lukatch Heath
Director
Transactions
- Sale
Common Stock
2024-01-31$71.50/sh−5,000$357,500→ 5,625 total - Exercise/Conversion
Stock Option (right to buy)
2024-01-31−5,000→ 6,000 totalExercise: $16.00Exp: 2030-06-10→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2024-01-31$16.00/sh+5,000$80,000→ 10,625 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2023.
- [F2]Fully vested and exercisable.